Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.


ATRYS HEALTH closes its capital increase with one of the largest shares oversubscription in the history of MAB.

February 21, 2018

Madrid, February 16, 2018.- Atrys Health, SA, a company dedicated to the provision of diagnostic services and medical treatments of excellence, has announced the closure of a full subscription of capital increase for a total cash amount of 4 million euros. which complements the two previous capital increases carried out at the end of December 2017 of € 7.9M and € 1.25M.

The Board of Directors of ATRYS held on February 15, proceeded to the discretionary allocation of the current issuance of a maximum of 2,816,900 new shares with a price or type of issue of 1.42 euros per title.

The increase has been subscribed in 736,800 shares by shareholders who have exercised their right of preferential acquisition and who represent 85% of the company's free float and the discretionary allocation tranche has received 306 requests amounting to 5,893,606 titles remaining at both oversubscribed by 283%.

"We are very pleased with the reception given to the capital increase by investors and the confidence shown by the company's current shareholders. The good performance of Atrys together with these three capital increase operations will allow us to accelerate its growth through strategic acquisitions, "said Santiago de Torres, CEO of Atrys.